scholarly article | Q13442814 |
P2093 | author name string | Caroline Nothdurfter | |
Cornelius Schüle | |||
Rainer Rupprecht | |||
P304 | page(s) | 79-87 | |
P577 | publication date | 2013-11-08 | |
P1433 | published in | Progress in Neurobiology | Q15716615 |
P1476 | title | The role of allopregnanolone in depression and anxiety | |
P478 | volume | 113 |
Q47877573 | 5α-reductase type I expression is downregulated in the prefrontal cortex/Brodmann's area 9 (BA9) of depressed patients. |
Q38374699 | A randomized controlled trial of ganaxolone in posttraumatic stress disorder |
Q38813972 | Adapting to Stress: Understanding the Neurobiology of Resilience |
Q36042637 | Alcohol and violence: neuropeptidergic modulation of monoamine systems |
Q60311366 | Allopregnanolone Treatment Improves Plasma Metabolomic Profile Associated with GABA Metabolism in Fragile X-Associated Tremor/Ataxia Syndrome: a Pilot Study |
Q34033021 | Allopregnanolone and neurogenesis in the nigrostriatal tract |
Q95269742 | Allopregnanolone in premenstrual dysphoric disorder (PMDD): Evidence for dysregulated sensitivity to GABA-A receptor modulating neuroactive steroids across the menstrual cycle |
Q91219821 | Allopregnanolone-based treatments for postpartum depression: Why/how do they work? |
Q64899064 | Animal Models of PTSD: The Socially Isolated Mouse and the Biomarker Role of Allopregnanolone. |
Q47349454 | Anxiolytic effects of hippocampal neurosteroids in normal and neuropathic rats with spared nerve injury |
Q89598496 | Association between Generalized Anxiety Disorder and Premenstrual Dysphoric Disorder in a Diagnostic Interviewing Study |
Q96109761 | Associations between PTSD-Related extinction retention deficits in women and plasma steroids that modulate brain GABAA and NMDA receptor activity |
Q58795417 | Astrocytes, emerging stars of energy homeostasis |
Q58798790 | Biomarkers for PTSD at the Interface of the Endocannabinoid and Neurosteroid Axis |
Q30374722 | Brain and Serum Androsterone Is Elevated in Response to Stress in Rats with Mild Traumatic Brain Injury. |
Q91641482 | Brexanolone, a neurosteroid antidepressant, vindicates the GABAergic deficit hypothesis of depression and may foster resilience |
Q47391434 | Dependence of anxiolytic effects of the dipeptide TSPO ligand GD-23 on neurosteroid biosynthesis. |
Q61806582 | Depression as a Neuroendocrine Disorder: Emerging Neuropsychopharmacological Approaches beyond Monoamines |
Q30275714 | Differential Effects of Estrogen and Progesterone on Genetic and Environmental Risk for Emotional Eating in Women |
Q90598904 | Effectiveness of self-empowerment-affirmation-relaxation (Self-EAR) program for postpartum blues mothers: A randomize controlled trial |
Q57818280 | Emerging Therapeutic Role of PPAR-α in Cognition and Emotions |
Q34435307 | Fluoxetine elevates allopregnanolone in female rat brain but inhibits a steroid microsomal dehydrogenase rather than activating an aldo-keto reductase. |
Q30363617 | GABA receptor subunit distribution and FMRP-mGluR5 signaling abnormalities in the cerebellum of subjects with schizophrenia, mood disorders, and autism. |
Q92543481 | GABA-A receptor modulating steroids in acute and chronic stress; relevance for cognition and dementia? |
Q26777461 | GABAA receptor modulating steroid antagonists (GAMSA) are functional in vivo |
Q28241963 | GABAA receptor-acting neurosteroids: a role in the development and regulation of the stress response |
Q30428666 | Ganaxolone improves behavioral deficits in a mouse model of post-traumatic stress disorder |
Q64460779 | Giving a good start to a new life via maternal brain allostatic adaptations in pregnancy |
Q61805522 | Kami-shoyo-san improves ASD-like behaviors caused by decreasing allopregnanolone biosynthesis in an SKF mouse model of autism |
Q39010909 | Koumine exhibits anxiolytic properties without inducing adverse neurological effects on functional observation battery, open-field and Vogel conflict tests in rodents |
Q47321573 | Lower allopregnanolone during pregnancy predicts postpartum depression: An exploratory study. |
Q92385675 | Memory impairment induced by different types of prolonged stress is dependent on the phase of the estrous cycle in female rats |
Q60808711 | Negative Association Between Allopregnanolone and Cerebral Serotonin Transporter Binding in Healthy Women of Fertile Age |
Q47134980 | Nestorone® as a Novel Progestin for Nonoral Contraception: Structure-Activity Relationships and Brain Metabolism Studies. |
Q47178563 | Neuroactive Steroids and Affective Symptoms in Women Across the Weight Spectrum |
Q57170039 | Neuroactive Steroids and Perinatal Depression: a Review of Recent Literature |
Q38396464 | Neuroactive steroids and the peripheral nervous system: An update. |
Q38191310 | Neurobiological correlates of social anxiety disorder: an update |
Q91646274 | Neurosteroid Levels in the Orbital Frontal Cortex of Subjects with PTSD and Controls: A Preliminary Report |
Q36626032 | Neurosteroidogenesis Today: Novel Targets for Neuroactive Steroid Synthesis and Action and Their Relevance for Translational Research |
Q34211338 | New perspectives in neurosteroid action: open questions for future research |
Q47424155 | Novel analogs of allopregnanolone show improved efficiency and specificity in neuroprotection and stimulation of proliferation |
Q33578483 | Open-label, proof-of-concept study of brexanolone in the treatment of severe postpartum depression |
Q90539097 | Pathophysiological mechanisms implicated in postpartum depression |
Q90685179 | Physiopathological role of the enzymatic complex 5α-reductase and 3α/β-hydroxysteroid oxidoreductase in the generation of progesterone and testosterone neuroactive metabolites |
Q48277387 | Plasma dehydroepiandrosterone sulfate levels in patients with major depressive disorder correlate with remission during treatment with antidepressants. |
Q92268146 | Pleiotropic actions of allopregnanolone underlie therapeutic benefits in stress-related disease |
Q37718994 | Pregnanolone Glutamate, a Novel Use-Dependent NMDA Receptor Inhibitor, Exerts Antidepressant-Like Properties in Animal Models |
Q26786009 | Premenstrual Dysphoric Disorder: Epidemiology and Treatment |
Q38198091 | Progesterone and its metabolites as therapeutic targets in psychiatric disorders |
Q38358214 | Programming the brain and behaviour by early-life stress: a focus on neuroactive steroids |
Q41109697 | Puerarin ameliorated the behavioral deficits induced by chronic stress in rats |
Q36799061 | Replication of Epigenetic Postpartum Depression Biomarkers and Variation with Hormone Levels |
Q41258644 | Rescue of deficient amygdala tonic γ-aminobutyric acidergic currents in the Fmr-/y mouse model of fragile X syndrome by a novel γ-aminobutyric acid type A receptor-positive allosteric modulator |
Q92139777 | SAGE-217, A Novel GABAA Receptor Positive Allosteric Modulator: Clinical Pharmacology and Tolerability in Randomized Phase I Dose-Finding Studies |
Q91123514 | Sex differences in steroid levels and steroidogenesis in the nervous system: Physiopathological role |
Q90124577 | Stress and drug abuse-related disorders: The promising therapeutic value of neurosteroids focus on pregnenolone-progesterone-allopregnanolone pathway |
Q21090552 | Temperament type specific metabolite profiles of the prefrontal cortex and serum in cattle |
Q92403518 | The Role of Allopregnanolone in Pregnancy in Predicting Postpartum Anxiety Symptoms |
Q47660464 | The anxiolytic-like effects of puerarin are associated with the changes of monoaminergic neurotransmitters and biosynthesis of allopregnanolone in the brain |
Q92204594 | The cerebellum under stress |
Q38271320 | The neuroprotective actions of oestradiol and oestrogen receptors |
Q38949384 | Translocator protein (TSPO) ligands for the diagnosis or treatment of neurodegenerative diseases: a patent review (2010-2015; part 1). |
Q58702659 | Translocator protein ligand, YL-IPA08, attenuates lipopolysaccharide-induced depression-like behavior by promoting neural regeneration |
Q89823249 | Use of Brexanolone for Postpartum Depression |
Q34288073 | Using drug combinations to assess potential contributions of non-GABAA receptors in the discriminative stimulus effects of the neuroactive steroid pregnanolone in rats |
Q38794340 | Why are women so vulnerable to anxiety, trauma-related and stress-related disorders? The potential role of sex hormones |
Q36289293 | Why may allopregnanolone help alleviate loneliness? |
Search more.